Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 EUR | -0.63% |
|
-1.26% | -5.99% |
06-06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
06-05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
I-MAB | Other Pharmaceuticals | -0.63% | -1.26% | - | - | - | 135M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- IMAB Stock
- 0VY Stock
- Charts I-Mab
- Comparison Chart